VIRI
Income statement / Annual
Last year (2023), Virios Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Virios Therapeutics, Inc.'s net income was -$5.30 M.
See Virios Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$1.73 M
|
$8.07 M
|
$10.80 M
|
$194,013.00
|
$836,175.00
|
$854,109.00
|
| General & Administrative
Expenses |
$3.72 M
|
$4.25 M
|
$4.85 M
|
$9.81 M
|
$1.34 M
|
$1.11 M
|
| Selling & Marketing
Expenses |
$3.72 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$3.72 M
|
$4.25 M
|
$4.85 M
|
$9.81 M
|
$1.34 M
|
$1.11 M
|
| Other Expenses |
$0.00 |
$67,475.00 |
-$319,328.00 |
-$341,001.00 |
$0.00 |
$6.00 |
| Operating Expenses |
$5.45 M |
$12.32 M |
$15.64 M |
$10.01 M |
$2.18 M |
$1.96 M |
| Cost And Expenses |
$5.45 M |
$12.32 M |
$15.64 M |
$10.01 M |
$2.18 M |
$1.96 M |
| Interest Income |
$150,904.00 |
$67,475.00 |
$5,672.00 |
$384.22 |
$295.13 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$5,672.00 |
$384,222.00 |
$295,128.00 |
$152,103.00 |
| Depreciation &
Amortization |
$5.45 M
|
$12.32 M
|
$15.64 M
|
$10.01 M
|
$2.18 M
|
$1.96 M
|
| EBITDA |
$150,904.00
|
-$12.32 M
|
-$15.64 M
|
-$10.01 M
|
-$295,128.00
|
-$152,097.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$150,904.00
|
$67,475.00
|
-$319,328.00
|
-$341,001.00
|
-$295,128.00
|
-$152,097.00
|
| Income Before Tax |
-$5.30 M |
-$12.25 M |
-$15.96 M |
-$10.35 M |
-$2.47 M |
-$2.11 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$5,446.92 |
-$67,475.00 |
-$15,640.94 |
-$10,005.39 |
$295,128.00 |
$152,103.00 |
| Net Income |
-$5.30 M |
-$12.18 M |
-$15.96 M |
-$10.35 M |
-$2.77 M |
-$2.11 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.28 |
-1.1 |
-1.92 |
-1.25 |
-0.33 |
-0.44 |
| EPS Diluted |
-0.28 |
-1.1 |
-1.92 |
-1.25 |
-0.33 |
-0.44 |
| Weighted Average Shares
Out |
$18.78 M
|
$11.07 M
|
$8.33 M
|
$8.31 M
|
$8.28 M
|
$4.83 M
|
| Weighted Average Shares
Out Diluted |
$18.78 M
|
$11.07 M
|
$8.33 M
|
$8.31 M
|
$8.28 M
|
$4.83 M
|
| Link |
|
|
|
|
|
|
